Visionary Wealth Advisors Gilead Sciences, Inc. Transaction History

Visionary Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $197,991 - $225,602	-3,495 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $3,105 - $3,904	50 Added 1.45%	3,495 $221,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $217 - $252	3 Added 0.09%	3,445 $265,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $8,204 - $10,508	131 Added 3.96%	3,442 $257,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $204,023 - $224,419	3,311 New	3,311 $216,000

1,924

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Visionary Wealth Advisors with notifications on news.